Immunai, which uses AI to analyze the human immune system, raises $60M Series A led by Schusterman Foundation and others (Kyle Wiggers/VentureBeat)

A new startup, Immunai, has recently emerged, with the aim of advancing research in the human immune system. The two founders are Noam Solomon and Luis Voloch. They are both engineers and scientists who have developed technology to analyse the human immune system

Read more